M. Helen Boudreau's most recent trade in Premier Inc - Ordinary Shares - Class A was a trade of 2,500 Class A Common Stock done at an average price of $21.4 . Disclosure was reported to the exchange on Jan. 6, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Premier Inc - Ordinary Sha... | Helen M. Boudreau | Director | Sale of securities on an exchange or to another person at price $ 21.42 per share. | 06 Jan 2025 | 2,500 | 20,668 (0%) | 0% | 21.4 | 53,550 | Class A Common Stock |
Premier Inc - Ordinary Sha... | Helen M. Boudreau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 7,101 | 23,168 (0%) | 0% | 0 | Class A Common Stock | |
Shattuck Labs Inc | Helen M. Boudreau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 27,700 | 27,700 | - | - | Stock Option (Right to Buy) | |
Cara Therapeutics Inc | Helen M. Boudreau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 195,000 | 195,000 | - | - | Stock Option (Right to Buy) | |
Cara Therapeutics Inc | Helen M. Boudreau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 150,647 | 150,647 (0%) | 0% | 0 | Common Stock | |
Rallybio Corp | Helen M. Boudreau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 16,500 | 16,500 | - | - | Option (Right to Buy) | |
Premier Inc - Ordinary Sha... | Helen M. Boudreau | Director | Sale of securities on an exchange or to another person at price $ 19.85 per share. | 15 May 2024 | 6,629 | 16,067 (0%) | 0% | 19.9 | 131,586 | Class A Common Stock |
Premier Inc - Ordinary Sha... | M. Helen Boudreau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2023 | 7,333 | 22,696 (0%) | 0% | 0 | Class A Common Stock | |
Shattuck Labs Inc | Helen M. Boudreau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 40,258 | 40,258 | - | - | Stock Option (Right to Buy) | |
Premier Inc - Ordinary Sha... | Helen M. Boudreau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2022 | 4,636 | 15,363 (0%) | 0% | 0 | Class A Common Stock | |
Rallybio Corp | Helen M. Boudreau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 13,440 | 13,440 | - | - | Option (Right to Buy) | |
Premier Inc - Ordinary Sha... | Helen M. Boudreau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2021 | 4,098 | 10,727 (0%) | 0% | 0 | Class A Common Stock | |
Shattuck Labs Inc | Helen M. Boudreau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jun 2021 | 3,434 | 3,434 | - | - | Stock Option (Right to Buy) | |
Shattuck Labs Inc | Helen M. Boudreau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2020 | 1,286 | 1,286 | - | - | Stock Option (Right to Buy) |